|
|
| | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Basic information |
| Product Name: | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- | | Synonyms: | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-;(1S,2S,10S,13R,14S,17S,18S)-2,17,18-trimethyl-6,7-diazapentacyclo[11.7.0.02,1?.0?,?.01?,1?]icosa-4,7-dien-17-ol | | CAS: | 302-96-5 | | MF: | C21H32N2O | | MW: | 328.49158 | | EINECS: | | | Product Categories: | | | Mol File: | 302-96-5.mol |  |
| | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Chemical Properties |
| Boiling point | 466.22°C (rough estimate) | | density | 1.0279 (rough estimate) | | refractive index | 1.6500 (estimate) |
| Toxicity | TDLo orl-wmn: 24 mg/kg/17W-I:SYS BMJOAE294,612,87 |
| | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Usage And Synthesis |
| Definition | ChEBI: Stanozolol is an organic heteropentacyclic compound resulting from the formal condensation of the 3-keto-aldehyde moiety of oxymetholone with hydrazine. Like oxymetholone, it is a synthetic anabolic steroid. It has both anabolic and androgenic properties, and has been used to treat hereditary angioedema and various vascular disorders. It has also been widely abused by professional athletes. It has a role as an androgen and an anabolic agent. It is a 17beta-hydroxy steroid, a tertiary alcohol, an anabolic androgenic steroid and an organic heteropentacyclic compound. It is functionally related to an oxymetholone. | | Safety Profile | Human systemic effects byingestion: jaundice. An experimental teratogen. Otherexperimental reproductive effects. When heated todecomposition it emits toxic fumes of NOx. |
| | 1H-Androstano3,2-cpyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)- Preparation Products And Raw materials |
|